Thinking Outside the Box in Mediastinal Lymphoma Management Marwa AlhamssRiad El Fakih Correspondence Open access 17 May 2023 Pages: 177 - 180
The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma Syed Maaz TariqAl-Ola AbdallahAlec Britt Correspondence Open access 03 May 2023 Pages: 170 - 176
Thromboembolism Early After Glucocorticoid Administration in Patients with Autoimmune Hemolytic Anemia Kohei ShiroshitaMikio OkayamaKen Sadahira Correspondence Open access 24 April 2023 Pages: 165 - 169
Clinical and Cytogenetic Characterization, and Outcome of Chronic Lymphocytic Leukemia Patients in a Single Tertiary Center in Saudi Arabia Areej Al MugairiEkremah AlzareaAhmed Alaskar Correspondence Open access 21 April 2023 Pages: 107 - 111
Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome Jean El-CheikhGhassan BidaouiAli Bazarbachi Review Article Open access 18 April 2023 Pages: 143 - 154
Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature Giulia CaddeoCristina TecchioSimone Cesaro Review Article Open access 18 April 2023 Pages: 130 - 138
Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH) Nizar J. BahlisLuciano J. CostaMohamad Mohty Prespective Open access 15 April 2023 Pages: 112 - 121
CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature Sara BowmanJoe StanekHemalatha G. Rangarajan Research Article Open access 07 April 2023 Pages: 155 - 164
Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review Israr KhanNida KhanFaiz Anwer Review Article Open access 03 April 2023 Pages: 122 - 129
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini Mohamad MohtyGiampaolo Merlini Prespective Open access 20 March 2023 Pages: 139 - 142
Another Year to Celebrate Advances in Clinical Hematology Mohamad MohtyJunia V. Melo Editorial Open access 20 March 2023 Pages: 1 - 2
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma Abdul-Hamid BazarbachiDaniel ReefRoberto Alejandro Sica Research Article Open access 15 March 2023 Pages: 78 - 91
Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes Eren Arslan DavulcuNur SoyerGüray Saydam Research Article Open access 24 February 2023 Pages: 101 - 106
The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia Sevastianos ChatzidavidChristina-Nefeli KontandreopoulouNora-Athina Viniou Research Article Open access 22 February 2023 Pages: 92 - 100
Co-occurrence of Multiple Sclerosis and Severe Aplastic Anemia: A Report of Two Cases Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation Alfadil HaroonSyed Osman AhmedHazzaa Alzahrani Correspondence Open access 17 February 2023 Pages: 61 - 64
Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03) Zoe van de WyngaertFlorent MalardChristian Chabannon Research Article Open access 12 February 2023 Pages: 38 - 42
Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Edward R. Scheffer CliffGemma ReynoldsAndrew Grigg Correspondence Open access 08 February 2023 Pages: 71 - 77
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period Kelly J. GaffneyTheresa A. UrbanSherif Beniameen Mossad Research Article Open access 04 February 2023 Pages: 65 - 70
Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma Samer Al HadidiDeepa DongarwarFrits van Rhee Correspondence Open access 03 February 2023 Pages: 57 - 60
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma Torben PlesnerSimon J. HarrisonFredrik Schjesvold Research Article Open access 19 January 2023 Pages: 43 - 51
Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia Mona Ali HassanNour MoukalledIman Abou Dalle Correspondence Open access 03 January 2023 Pages: 52 - 55
Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review Andrea Anampa-GuzmánSara Taveras AlamSamer Al Hadidi Research Article Open access 31 December 2022 Pages: 29 - 37
The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients Johnny ZakhourFatima AllawSouha S. Kanj Review Article Open access 29 December 2022 Pages: 21 - 28
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms Carmelo GurnariZhuoer XieAmer M. Zeidan Review Article Open access 27 December 2022 Pages: 8 - 20
Effects of Erythrocytapheresis Procedures on Delayed Bone Marrow Conversion in Sickle Cell Disease Emily PophamKaren MoellerAshok Raj Research Article Open access 16 November 2022 Pages: 144 - 147
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle Mohamad MohtyRobert A. Kyle Prespective Open access 08 November 2022 Pages: 3 - 7
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study Ann JanssensZwi N. BernemanMarc André Research Article Open access 13 October 2022 Pages: 133 - 143
FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL Caroline DartigeasBorhane SlamaVeronique Leblond Research Article Open access 14 September 2022 Pages: 65 - 74
Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective Ahmad IbrahimNabil ChamseddineAli Bazarbachi Prespective Open access 30 August 2022 Pages: 127 - 132
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb Mohamad MohtyRainer Storb Prespective Open access 29 August 2022 Pages: 121 - 126
Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series Shamis KhanSara Taveras AlamSarvari Venkata Yellapragada Correspondence Open access 23 August 2022 Pages: 148 - 151
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens Katrine Fladeland IversenLine NederbyTorben Plesner Research Article Open access 09 August 2022 Pages: 107 - 116
Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States Samer Al HadidiDeepa DongarwarFrits van Rhee Correspondence Open access 29 July 2022 Pages: 117 - 120
Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation Sayako YudaShigeo FujiKatie S. Gatwood Review Article Open access 11 July 2022 Pages: 89 - 98
The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities Rose EllardMichelle KenyonJohn Murray Review Article Open access 08 July 2022 Pages: 75 - 88
Organizational Challenges in the Pediatric Onco-hematology Units During the First and Second Wave of the COVID-19 Pandemic: A National Survey in Italy Matteo AmicucciValentina BiagioliMoreno Crotti Partel Research Article Open access 23 June 2022 Pages: 99 - 106
Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina Carolina MahuadOtero VictoriaCugliari Silvana Research Article Open access 22 June 2022 Pages: 44 - 51
Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas Ibrahim N. MuhsenRiad El FakihMahmoud Aljurf Review Article Open access 22 June 2022 Pages: 1 - 10
Invasive Fungal Rhinosinusitis Due to Co-infection with Mucormycosis and Exserohilum rostratum in a Patient with Acute Lymphoblastic Leukemia Vera RadiciEolia BrissotAlexis Genthon Correspondence Open access 13 June 2022 Pages: 60 - 64
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia Obada AbabnehHassan AbushukairSamer Al Hadidi Review Article Open access 23 May 2022 Pages: 21 - 29
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine Marco ManzoniAlessandro BosiNiccolò Bolli Correspondence Open access 12 May 2022 Pages: 52 - 55
Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Ali IbrahimNour MoukalledIman Abou Dalle Research Article Open access 12 May 2022 Pages: 30 - 34
Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma Kellen GilSaqib AbbasiGhulam Rehman Mohyuddin Correspondence Open access 11 May 2022 Pages: 56 - 59
Selected Domains within a Comprehensive Geriatric Assessment in Older Patients with Non-Hodgkin Lymphoma are Highly Associated with Frailty María del Pilar Gamarra SamaniegoCarmelo J. BlanquicettBrady Ernesto Beltrán Garate Research Article Open access 11 May 2022 Pages: 35 - 43
Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence? Anna KomitopoulouI. BaltadakisE. Goussetis Review Article Open access 11 May 2022 Pages: 11 - 20
How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia Fiona FernandoHarry Frederick RobertsonJiří Pavlů Review Open access 29 November 2021 Pages: 130 - 141
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience Didier BlaisePierre BergerPatrice Viens Special Article Open access 27 September 2021 Pages: 119 - 129
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation Giuseppe TarantinoFrancesco SaraceniAttilio Olivieri Research Article Open access 23 September 2021 Pages: 161 - 168
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently Francesco SaraceniIlaria ScortechiniAttilio Olivieri Review Open access 19 August 2021 Pages: 153 - 160
CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust Eliza WiercinskaErhard SeifriedHalvard Bonig Research Article Open access 02 August 2021 Pages: 103 - 107
